Bromhexine-ferein

Contraindications

Hypersensitivity, first trimester of pregnancy, breast-feeding.

Incompatibilities

Preparations containing codeine make it difficult to discharge liquefied sputum. Promotes the penetration of antibiotics, including tetracyclines, erythromycin, cephalexin and sulfonamides into the bronchial mucosa and lung tissue.

Undesirable effects

Rarely, with prolonged use — nausea, vomiting, dyspeptic phenomena, exacerbation of gastric ulcer and duodenal ulcer, increased levels of transaminases in the blood serum, allergic reactions (skin rash, rhinitis, etc.).

Special instructions

Prescribing on the background of gastric ulcer disease or in patients with a history of gastric bleeding requires additional medical supervision.

Therapeutic indications

Acute and chronic inflammatory diseases of the lungs, accompanied by the formation of difficult-to-separate viscous sputum (bronchial asthma, cystic fibrosis, tuberculosis, pneumonia, tracheobronchitis, obstructive bronchitis, bronchiectasis, emphysema of the lungs, pneumoconiosis), chest injuries.

Pharmacotherapeutic group

  • Secretolytics and stimulants of motor function of the respiratory tract

Pharmacokinetic properties

After oral administration, almost completely (99%) is absorbed within 30 minutes. Bioavailability-80%, binds to plasma proteins, passes through the BBB and placental barrier. It is metabolized in the liver, partially with the formation of active metabolites. T1/2 — 1 h, in the terminal phase-15 h (due to reverse diffusion from the tissues). It is excreted by the kidneys, with repeated use it can accumulate. Against the background of severe hepatic impairment, the clearance decreases, and in chronic renal failure, the excretion of metabolites is disrupted.

Special precautions for storage

In a cool, dark place.

Keep out of reach of children.

Shelf life of the drug Bromhexin-Ferein®2 года.

Do not use after the expiration date indicated on the package.

Nature and contents of container

5 ml of syrup contains 4 mg of bromhexine, in glass bottles of 60 or 100 ml, in a cardboard pack 1 bottle complete with a measuring spoon.

Nosological classification (ICD-10)

  • A15-A19 Tuberculosis
  • E84. 0 Cystic fibrosis with pulmonary manifestations
  • J18 Pneumonia without specifying the causative agent
  • J40 Bronchitis, not specified as acute or chronic
  • J42 Chronic bronchitis, unspecified
  • J43 Emphysema
  • J44 Other chronic obstructive pulmonary disease
  • J45 Asthma
  • J47 Bronchiectatic disease [bronchiectasis]
  • J64 Pneumoconiosis, unspecified
  • J84. 1 Other interstitial lung diseases with reference to fibrosis
  • R09. 3 Sputum

Dosage (Posology) and method of administration

Inside (regardless of food intake), adults and children over 14 years — 8-16 mg (2-4 hours).spoons) 3 times a day, for children from 6 to 14 years-4-8 mg (1-2 hours).spoons) 3 times a day, for children from 2 to 6 years — 2-4 mg (1/2–1 hour).spoon) 3 times a day, for children under 2 years - 2 mg (1/2 teaspoon) 3 times a day. The course of treatment is from 4 to 28 days. In the course of treatment, it is recommended to consume a sufficient amount of liquid.

ATC - Anatomical and therapeutic chemical classification

R05CB02 Bromhexine